Psychedelic Harm Reduction: 77 - Rilegato

Rilegato

ISBN 10: 3032211069 ISBN 13: 9783032211064

Casa editrice: Springer Nature Switzerland AG, 2026

Riassunto

Scientific interest in classic psychedelics such as psilocybin, LSD, and 5-MeO-DMT has resurged, with promising results for the treatment of  mental health conditions including depression, anxiety, and substance use disorders. At the same time, public interest in those substances has increased, giving rise to what has been labelled as a "psychedelic renaissance". Although it has been repeatedly emphasized that psychedelics are not addictive and exhibit very low toxicity, their use is nevertheless associated a range of rare, but considerable risks and potential harms which may even occur after sporadic use. To date, these risks remain underrecognized and underresearched, and many clinical psychiatrists and psychologist are insufficiently informed about their pathophysiology, differential diagnosis and clinical management. This book addresses this gap by providing health care professionals and researchers with foundational information on the risks and adverse effects associated with the use of classic psychedelics.

The chapter "Classifying Psychedelic-Related Complications" is available open access under the Creative Commons AttributionNonCommercial-NoDerivatives 4.0 International License via link.springer.com.

Su questo libro

Informazioni sull'autore

Dr. med. Tomislav Majić: Licensed psychiatrist and psychotherapist in Berlin, Germany, with a focus on psychosis, substance use, double diagnosis and harm reduction. Studied medicine at Charité University Clinic Berlin until 2005. Co-founder and lead of „Psychedelic Substances Research Group" at Charité. Lecturer and supervisor for psychodynamic therapy at Berlin Institute for Psychotherapy and Psychoanalysis (BIPP). Founder of day clinic for patients with double diagnoses (2017) and outpatient treatment for patients suffering from psychedelic-related disorders (2017) ("Ambulanz Psychedelische Substanzen") at Psychiatric University Clinic of Charité at Hospital St. Hedwig Berlin. Study therapist and researcher  investigating therapeutic effects of classic psychedelics as well as psychedelic-related complications

Dalla quarta di copertina

Scientific interest in classic psychedelics such as psilocybin, LSD, and 5-MeO-DMT has resurged, with promising results for the treatment of  mental health conditions including depression, anxiety, and substance use disorders. At the same time, public interest in those substances has increased, giving rise to what has been labelled as a "psychedelic renaissance". Although it has been repeatedly emphasized that psychedelics are not addictive and exhibit very low toxicity, their use is nevertheless associated a range of rare, but considerable risks and potential harms which may even occur after sporadic use. To date, these risks remain underrecognized and underresearched, and many clinical psychiatrists and psychologist are insufficiently informed about their pathophysiology, differential diagnosis and clinical management. This book addresses this gap by providing health care professionals and researchers with foundational information on the risks and adverse effects associated with the use of classic psychedelics.

The chapter "Classifying Psychedelic-Related Complications" is available open access under the Creative Commons AttributionNonCommercial-NoDerivatives 4.0 International License via link.springer.com.

Dettagli dell'edizione

• Editore: Springer Nature Switzerland AG
• Data di pubblicazione: 2026
• Lingua: Inglese
• ISBN 10: 3032211069
• ISBN 13: 9783032211064
• Rilegatura: Copertina rigida
• Redattore: Majić Tomislav
• Contatto del produttore: Springer Nature Customer Service Center GmbH; ProductSafety@springernature.com; ; Europaplatz 3; Heidelberg; 69115; Germania